Page last updated: 2024-09-04

docetaxel anhydrous and Osteogenic Sarcoma

docetaxel anhydrous has been researched along with Osteogenic Sarcoma in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.85)	18.2507
2000's	6 (23.08)	29.6817
2010's	18 (69.23)	24.3611
2020's	1 (3.85)	2.80

Authors

Authors	Studies
Aoki, Y; Bouvet, M; Hamada, K; Han, Q; Hoffman, RM; Nishida, K; Tome, Y; Wu, NF; Yamamoto, J	1
Cai, L; Guo, W; Jin, L; Luo, Y; Tang, X; Tao, F; Tao, H; Zhang, Z; Zhao, Y	1
Constantinidou, A; Jones, RL; Loggers, E; Pollack, S; Rodler, E	1
Kim, DH; Lee, JA; Lim, JS; Seo, J; Song, BS; Yoo, JY	1
Wang, W; Wang, Z; Xiao, X	1
Chen, G; Fan, B; Fan, H; Fu, J; Gao, P; Guo, Z; Hu, Y; Huang, C; Li, J; Li, X; Shi, L; Wang, W; Wang, Z; Wu, S; Wu, Z; Xiao, X; Xu, C; Yu, X; Zhang, H; Zhu, H	1
Li, QH; Liu, P; Sun, L; Zhang, P; Zhou, DS	1
Gao, JF; Huang, XY; Jing, SF; Li, CD; Wang, DZ; Wei, H	1
Kim, DH; Kim, MS; Lee, JA; Lim, JS; Paik, EK; Seo, J; Yoo, JY	1
Asaftei, S; Cesari, M; Coccoli, L; Fagioli, F; Ferrari, S; Grignani, G; Jones, RL; Longhi, A; Marchesi, E; Meazza, C; Paioli, A; Palmerini, E; Picci, P; Pollack, SM; Tamburini, A	1
Ahn, HS; Baek, HJ; Cho, WH; Choi, HS; Im, HJ; Jeon, DG; Kang, HJ; Koh, KN; Koo, HH; Kook, H; Lee, JA; Lee, JW; Lim, YJ; Park, BK; Park, HJ; Park, KD; Seo, JJ; Shin, HY; Song, WS; Sung, KW; Yoo, KH; Yoon, HS	1
Kitawaki, J; Kokabu, T; Konishi, E; Mori, T; Tsukasaki, N; Yasukawa, S	1
Chuman, H; Hatano, H; Hiraga, H; Hosaka, M; Iwamoto, Y; Joyama, S; Kaya, M; Kubo, T; Morioka, H; Nagano, A; Nishida, Y; Takahashi, M; Tanaka, K; Toguchida, J; Tsumura, H; Yoshikawa, H	1
Gorlick, R; O'Day, K	1
Cai, L; Jin, W; Niu, G; Tao, H	1
Cruz, CO; de Torres, C; Mora, J; Parareda, A	1
Ben-Ami, T; Gosiengfiao, Y; Reichek, J; Walterhouse, D; Woodman, J	1
Benjamin, RS; Chawla, S; Chugh, R; Fox, E; Harmon, D; Helman, LJ; Patel, S; Reinke, D; Schuetze, S; Wathen, JK	1
He, AN; Lin, F; Qi, WX; Shen, Z; Tang, LN; Yao, Y	1
He, A; Huang, Y; Qi, W; Shen, Z; Sun, Y; Yang, Y; Yao, Y; Zhao, H	1
Lim, YL; Tay, EY	1
Daw, NC; Furman, W; McCarville, MB; Navid, F; Roberts, W; Watkins, A; Willert, JR	1
Bos, GD; Burns, BS; Edin, ML; Lester, GE; Tuttle, HG; Wall, ME; Wani, MC	1
Peng, L; Wang, Q; Wang, Z	1
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K	1
Bissery, MC; Guénard, D; Guéritte-Voegelein, F; Lavelle, F	1

Reviews

3 review(s) available for docetaxel anhydrous and Osteogenic Sarcoma

Article	Year
The evolution of systemic therapy in sarcoma. Expert review of anticancer therapy, 2013, Volume: 13, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin	2013
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatric drugs, 2014, Volume: 16, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids	2014
Novel therapeutic agents for osteosarcoma. Expert review of anticancer therapy, 2009, Volume: 9, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Docetaxel; Dogs; Drug Delivery Systems; Folic Acid Antagonists; Gemcitabine; Humans; Immunologic Factors; Neoadjuvant Therapy; Neoplasm Proteins; Osteosarcoma; Protein Kinase Inhibitors; Radiopharmaceuticals; Signal Transduction; Survival Rate; Taxoids; Xenograft Model Antitumor Assays; Young Adult	2009

Trials

3 trial(s) available for docetaxel anhydrous and Osteogenic Sarcoma

Article	Year
Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience. Pediatric blood & cancer, 2014, Volume: 61, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Male; Osteosarcoma; Republic of Korea; Retrospective Studies; Survival Rate; Taxoids	2014
Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Disease Progression; Docetaxel; Female; Gemcitabine; Humans; Male; Osteosarcoma; Outpatients; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Survival Analysis; Taxoids; Treatment Outcome	2009
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. The oncologist, 2012, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chondrosarcoma; Deoxycytidine; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Sarcoma, Ewing; Taxoids	2012

Other Studies

20 other study(ies) available for docetaxel anhydrous and Osteogenic Sarcoma

Article	Year
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model. Anticancer research, 2021, Volume: 41, Issue:4 Topics: Administration, Oral; Adolescent; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbon-Sulfur Lyases; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mice, Nude; Osteosarcoma; Recombinant Proteins; Tibia; Xenograft Model Antitumor Assays	2021
Synergistic effect of docetaxel combined with cisplatin on inhibiting human osteosarcoma in nude mice. Biochemical and biophysical research communications, 2018, 10-28, Volume: 505, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; Docetaxel; Drug Synergism; Heterografts; Humans; Mice; Mice, Nude; Osteosarcoma; Tumor Burden	2018
Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Gene Expression Regulation, Neoplastic; Genotype; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Mutation; Neoplasm Proteins; Osteosarcoma; Precision Medicine; Prognosis; Taxoids; Treatment Outcome	2015
Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma. International journal of pharmaceutics, 2015, Jan-15, Volume: 478, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Deoxycytidine; Docetaxel; Drug Combinations; Drug Liberation; gamma-Cyclodextrins; Gemcitabine; Humans; Liposomes; Mice, Nude; Nanostructures; Osteosarcoma; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays	2015
Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel. Drug research, 2015, Volume: 65, Issue:11 Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Matrix Metalloproteinase 9; Osteosarcoma; Taxoids; Time Factors; Wnt Signaling Pathway	2015
Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Osteosarcoma; Radiotherapy Dosage; Radiotherapy, Adjuvant; Republic of Korea; Retrospective Studies; Taxoids; Treatment Outcome	2016
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. BMC cancer, 2016, Apr-20, Volume: 16 Topics: Adolescent; Adult; Aged; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Osteosarcoma; Recurrence; Sarcoma; Taxoids; Treatment Outcome	2016
Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy. Pediatric blood & cancer, 2016, Volume: 63, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Osteosarcoma; Retrospective Studies; Taxoids	2016
Primary osteosarcoma of the uterine corpus: A case report. The journal of obstetrics and gynaecology research, 2016, Volume: 42, Issue:11 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Hysterectomy; Lung Neoplasms; Middle Aged; Osteosarcoma; Taxoids; Treatment Outcome; Uterine Neoplasms	2016
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients. World journal of surgical oncology, 2016, Dec-08, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Feasibility Studies; Gemcitabine; Humans; Japan; Middle Aged; Neutropenia; Osteosarcoma; Pneumonia; Retrospective Studies; Sarcoma; Taxoids; Treatment Outcome; Tubulin Modulators; Young Adult	2016
Proliferation inhibition effect of docetaxel combined with cisplatin on osteosarcoma cells. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Growth Inhibitors; Humans; Osteosarcoma; Taxoids	2010
Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:2 Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Combined Modality Therapy; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Male; Neoplasm Recurrence, Local; Neurosurgical Procedures; Osteosarcoma; Retrospective Studies; Taxoids; Treatment Outcome	2012
Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; China; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Osteosarcoma; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome	2012
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience. International journal of clinical oncology, 2013, Volume: 18, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Osteosarcoma; Prospective Studies; Taxoids	2013
Toxic erythema of chemotherapy with periorbital and perioral involvement. Singapore medical journal, 2012, Volume: 53, Issue:11 Topics: Antineoplastic Agents; Axilla; Bone Neoplasms; Child; Deoxycytidine; Docetaxel; Erythema; Female; Femur; Gemcitabine; Humans; Hyperpigmentation; Lung Neoplasms; Mouth; Orbit; Osteosarcoma; Taxoids; Treatment Outcome	2012
Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer, 2008, Jul-15, Volume: 113, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Male; Osteosarcoma; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2008
Selective drug resistant human osteosarcoma cell lines. Clinical orthopaedics and related research, 2001, Issue:383 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Docetaxel; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Immunohistochemistry; Osteosarcoma; Paclitaxel; Taxoids; Tumor Cells, Cultured	2001
[Docitaxol-induction apoptosis of osteosarcoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2001, Volume: 23, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; Docetaxel; Humans; Osteosarcoma; Paclitaxel; Taxoids; Tumor Cells, Cultured	2001
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine	2002
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer research, 1991, Sep-15, Volume: 51, Issue:18 Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Docetaxel; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Paclitaxel; Pancreatic Neoplasms; Sarcoma, Experimental; Taxoids	1991